InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,973.10
(
0.74%
)
US TECH 100
20,567.20
(
0.12%
)
Dow Jones
43,729.34
(
0.00%
)
Brent Oil
74.50
(
-1.28%
)
Bitcoin
76,090.34
(
0.25%
)

Replies to post #4646 on GTC Biotherapeutics (fka GTCB)

Replies to #4646 on GTC Biotherapeutics (fka GTCB)
icon url

DewDiligence

11/13/07 8:55 AM

#5564 RE: DewDiligence #4646

CRXL will update investors on its Factor V Leiden/Cambridge program on its 4Q07 CC in Mar 2008. (Source: Today’s CRXL CC)
icon url

DewDiligence

03/12/08 10:05 AM

#8953 RE: DewDiligence #4646

One fewer competitor in the hemophilia-with-inhibitors arena: CRXL reported today that its Factor V program is heading back to the drawing board after early-stage testing did not pan out.